GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study
Pictured: Illustration of a GLP-1 injection pen against a light blue background/iStock, KKStock GLP-1 receptor agonists continue showing their therapeutic potential beyond obesity and diabetes, with a new study indicating that the drug class could …